PSA Vice President Professor Mark Naunton MPS[/caption]
Dr Louise Schaper at PSA25[/caption]
PBS-backed esketamine rolls out for depression with S8 controls
Esketamine will soon be funded for treatment-resistant depression, requiring pharmacists to adhere to strict supply and handling conditions.
Pancreatic cancer: a deadly disease in the elderly
A 74-year-old man who had been self-medicating with antacids for recurrent indigestion consulted his GP when symptoms persisted for three months. After assessment, his...
Chlorodyne: the quadruple threat
A popular wonder drug of the 19th century, this patent medicine packed multiple punches.
In 1848, Dr John Collis Browne had a problem. After training...
Are you prepared for the new ODT program?
The new Opioid Dependence Treatment Program kicks off on 1 July. Here's the steps you need to take before, during and after the transition.
Full identification needed for ASL registration
Pharmacists are required to access a patient’s photo identification in many situations when dealing with the Active Script List (ASL).
Pharmacists to deliver COVID-19 vaccine
Federal Minister for Health Greg Hunt announced last week that pharmacists will be involved in the national COVID-19 vaccine rollout strategy, starting from Phase 2a.
